According to the International Diabetes Federation (IDF), roughly 536 million persons (aged 20 to 79) worldwide had diabetes in 2021, and this number is expected to climb to 783 million by 2045. The increasing prevalence of the condition demands pharmaceutical treatment, which boosts pharmaceutical excipient production and market growth. An growth in the number of chronic diseases, higher awareness of physical well-being, and rising incidence of lifestyle diseases such as diabetes and obesity-related disorders have all contributed to increased demand for medications around the world. This has spurred the demand for and production of medicines and excipients. Excipients are thought to aid active pharmaceutical components in achieving superior functionality, such as a longer shelf-life, as well as providing a competitive edge in formulation.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-excipients-market
Data Bridge Market Research analyses that the excipients market is expected to grow at a CAGR of 6.0% in the forecast period of 2021 to 2028 and is expected to reach USD 11,244.15 million by 2028. The rising demand for multifunctional excipients and increased use of generic pharmaceuticals are predicted to be the main drivers of revenue growth. Excipients have been recognized as providing improved functioning and a competitive advantage in drug formulations, which has led to an increase in their use by pharmaceutical companies in recent years. The market has gotten a boost from ongoing research and the identification of ideal or near-ideal chemicals that can be used in therapeutic formulations and delivery. Another element driving global growth is the development of increasingly sophisticated excipients with a greater involvement in medication delivery by most pharmaceutical companies.
Rising demand for biopharmaceuticals is expected to drive the market's growth rate during the forecast period 0f 2021-2028
The surging demand for biopharmaceuticals is anticipated to enhance the demand for market's growth rate. Due to their closeness to natural biological substances found in the human body, biopharmaceuticals are becoming increasingly popular in the healthcare business. As a result, they provide great efficacy with fewer adverse effects. They are one of the pharmaceutical industry's fastest-growing segments. Novel approaches such as regenerative medicine are constantly being refined. This has opened the door to even further expansion in this industry. Pharmaceutical companies can command high costs for novel treatments because of the safety and efficacy associated with biopharmaceutical products and their capacity to treat previously untreatable diseases. This contributes significantly to their overall revenue.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2021 to 2028
|
Base Year
|
2020
|
Historic Years
|
2019 (Customizable to 2013 - 2018)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemical Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Aclohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Disintegrants, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg , Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific , Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa
|
Market Players Covered
|
BASF SE (Germany), DuPont (U.S.), Roquette Feres (France), Evonik Industries AG (Germany), JRS PHARMA (Germany), The Lubrizol Corporation (A Subsidiary of Berkshire Hathaway Inc.) (U.S.), Kerry Group PLC (Ireland), Shin-Etsu Chemical Co., Ltd (Japan), Colorcon (U.S.), Chemische Fabrik Budenheim (Germany), Peter Greven GmbH & Co. KG (Germany), ADM (U.S.), Croda International Plc (U.K.), BENEO (Germany), Avantor, Inc. (U.S.), Omya AG (Switzerland), DFE Pharma (Germany), Pfanstiehl, Inc. (U.S.), MEGGLE Group Wasserburg (Germany)
|
Data Pointers Covered in Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The excipients market is segmented on the basis of origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel.
In 2021, the organic segment of origin segment is anticipated to dominate the excipients market
In 2021, the organic segment of this market will dominate the excipients market due to non-toxic characteristic of organic chemicals used as excipients. The organic segment is expected reach the highest CAGR of 6.4% in the forecast period of 2021-2028.
In 2021, the direct tender segment is projected to hold the largest share of distribution channel segment in the excipients market
In 2021, the direct tender segment is anticipated to hold the largest share of the global excipients market because the end users (such as pharmaceutical and biopharmaceutical companies) use the excipients in bulk quantity for the manufacturing of medicines. Hence, these companies did direct tender with the excipients companies for further manufacturing. The direct tender segment is growing with a CAGR of 6.6% in the forecast period of 2021 to 2028.
Major Players
Data Bridge Market Research recognizes the following companies as the major BASF SE (Germany), DuPont (U.S.), Roquette Feres (France), Evonik Industries AG (Germany), JRS PHARMA (Germany), The Lubrizol Corporation (A Subsidiary of Berkshire Hathaway Inc.) (U.S.), Kerry Group PLC (Ireland), Shin-Etsu Chemical Co., Ltd (Japan).
Market Development
Regional Analysis
Geographically, the countries covered in the Excipients market report are U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg , Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific , Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa.
As per Data Bridge Market Research analysis:
North America is the dominant region in Excipients market during the forecast period 2021 - 2028
North America will continue to dominate the Excipients market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to the presence of major key players and the increasing number of research activities in this region. U.S. is estimated to dominate the North American region due to the technological advancements in multifunctional excipients and rising need for pharmaceutical products across varied therapeutic areas.
Asia-Pacific is estimated to be the fastest-growing region in Excipients market the forecast period 2021 - 2028
Asia-Pacific region is anticipated to grow at the highest rate during the forecast period of 2021-2028 due to the expanding generic market and high volume of unmet medical need in the region. China is anticipated to dominate the Asia-Pacific region due to the surging demand and availability of generic drugs and innovation in biopharmaceuticals.
COVID-19 Impact Analysis
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. The virus was rapidly spreading, so the authorities enforced a lockdown to stop it. The COVID-19 outbreak significantly impacted the world economy and all sectors. The worldwide pharmaceutical excipients industry, like other industries, was severely impacted by the COVID-19 pandemic. The abrupt enforcement of lockdown and social distance requirements disrupted the main pharmaceutical excipient firms' raw material delivery channel and supply chain. The lack of supplies has an impact on countries including China and India, resulting in a reduction in medication production all over the world. The pharmaceutical excipients sector benefited from the COVID-19 as well. Pharmaceutical excipients were utilized in R&D to find a vaccine combination for the virus, and it had a significant impact on several healthcare industries. However, it had a negative impact on pharmaceutical excipients in general.
For more detailed information about the Excipients market report, click here – https://www.databridgemarketresearch.com/reports/global-excipients-market
Global Excipients Market – Industry Trends and Forecast to 2028
Asia-Pacific Excipients Market – Industry Trends and Forecast to 2028
Europe Excipients Market – Industry Trends and Forecast to 2028
Middle East and Africa Excipients Market – Industry Trends and Forecast to 2028
North America Excipients Market – Industry Trends and Forecast to 2028
Global Pharmaceutical Excipients Market – Industry Trends and Forecast to 2029
Global Nutraceutical Excipient Market – Industry Trends and Forecast to 2028
Global Sugar-Based Excipients Market – Industry Trends and Forecast to 2028
DOW, JRS Pharma and Shin-Etsu Chemical Co., Ltd. are Dominating the Asia-Pacific Excipients Market in 2021